|
QNTM Quantum Biopharma Ltd 1771885 |
| Income Statement |
|
Net Income
|
2025-09-30
|
$-4,747,600.00 |
| Balance Sheet |
|
Current Assets
|
$6,478,353.00 |
|
Assets
|
$11,160,909.00 |
|
Current Liabilities
|
$6,058,294.00 |
|
Liabilities
|
$6,058,294.00 |
|
Equity
|
$5,102,615.00 |
|
Shares Out
|
72.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-8,237,012.00 |
|
Investing Cash Flow
|
$-1,952,469.00 |
| Market Analysis |
Market Cap
|
$204.48 |
|
Price
|
$2.89 |
|
BVPS
|
70869.65 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:42 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:42 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view QNTM documents filed with the SEC.
QNTM Filings
Clear
